India, Sept. 10 -- Rio Tinto Group (RIO.AX), a mining company, Wednesday announced that it has signed project agreement with The Nyangumarta Warrarn Aboriginal Corporation or NWAC for the proposed Win... Read More
India, Sept. 10 -- Indian shares were little changed in cautious trade on Thursday as the Middle East conflict showed no signs of easing and caution set in ahead of the release of crucial U.S. inflati... Read More
India, Sept. 10 -- Tobila Systems Inc. (4441.T) announced a profit for nine months of JPY516 million The company's earnings totaled JPY516 million, or JPY50.39 per share. This compares with JPY516 mi... Read More
India, Sept. 9 -- Serina Therapeutics Inc. (SER), a clinical-stage biotechnology company, on Wednesday reported the completion of a blinded review evaluating Cohort 1 data from the Phase 1b trial for ... Read More
India, Sept. 9 -- Recruitment firm SThree plc (STEM.L) announced on Wednesday that it has received an unsolicited, preliminary and highly conditional approach from Circle8 Group Inc. regarding a possi... Read More
India, Sept. 9 -- AIM ImmunoTech Inc. (AIM) highlighted the scientific rationale, supportive data and continued clinical development of Ampligen (rintatolimod) in pancreatic cancer in a new installmen... Read More
India, Sept. 9 -- Context Therapeutics Inc. (CNTX), a clinical-stage biopharmaceutical company, announcement on Wednesday the dosing of the first patient in the Phase 1 trial for CT-202 in treating Ne... Read More
India, Sept. 9 -- Opus Genetics, Inc. (IRD) is trading at $5.99, up $1.64 or 37.90 percent from its previous close of $4.34 on Wednesday. The stock opened at $5.33 and has traded between $5.32 and $7... Read More
India, Sept. 9 -- Stellantis N.V. (STLA), parent company of Chrysler, is recalling certain vehicles due to a software defect that may cause the tire pressure monitoring system to fail to detect low ti... Read More
India, Sept. 9 -- Turn Therapeutics Inc. (TTRX), a clinical-stage biotechnology company, on Wednesday announced the appointment of Robert R. Redfield, M.D., former Director of the U.S. Centers for Dis... Read More